Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kirkpatrick, JP; Vredenburgh, JJ; Desjardins, A; Gururangan, S; Peters, KB; Boulton, ST; Friedman, AH; Friedman, HS; Reardon, DA

Published Date

  • May 20, 2009

Published In

Volume / Issue

  • 27 / 15

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 29, 2009

Conference End Date

  • June 2, 2009